Kimberly Pitner, R.N.

Division of Endocrinology, Children’s National Hospital
Washington, United States

Disclosure information not submitted.

Presentation(s):

• ORF47-07 - Vosoritide Improves Growth in RASopathies, Aggrecan and NPR2 Deficiency: A Phase 2 Trial

  Monday, June 15, 2026
  2:45 PM - 3:00 PM CT

• ORF47-08 - Vosoritide Treatment in Children with Hypochondroplasia: Three-Year Results from A Phase II Extension Trial

  Monday, June 15, 2026
  3:00 PM - 3:15 PM CT